Citation Impact
Citing Papers
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
2014 Standout
STING Ligand c-di-GMP Improves Cancer Vaccination against Metastatic Breast Cancer
2014
PIK3R1 (p85α) Is Somatically Mutated at High Frequency in Primary Endometrial Cancer
2011
Physical activity, sedentary behaviours, and the prevention of endometrial cancer
2010
Beyond the numbers of maternal near-miss in Rwanda – a qualitative study on women’s perspectives on access and experiences of care in early and late stage of pregnancy
2016
Metabolic Syndrome and Cancer
2009
Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres
2010 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
mTOR Signaling in Growth Control and Disease
2012 Standout
Inhibition of inducible isoforms of cyclooxygenase and nitric oxide synthase by flavonoid hesperidin in mouse macrophage cell line
2003
A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease
2010
The FGF family: biology, pathophysiology and therapy
2009 Standout
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
2014 Standout
Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy
2011
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Natural products: An evolving role in future drug discovery
2011 Standout
Anthropometric factors and endometrial cancer risk: a systematic review and dose–response meta-analysis of prospective studies
2015
mTOR inhibitors in the treatment of cancer
2008
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
2015 Standout
The emerging role of lncRNAs in cancer
2015 Standout
Programmable RNA Tracking in Live Cells with CRISPR/Cas9
2016 StandoutNobel
Deforolimus (AP23573) a novel mTOR inhibitor in clinical development
2008
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
2019 Standout
Rapamycin: One Drug, Many Effects
2014 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
mTOR signaling and drug development in cancer
2010
Regional disparities in antenatal care utilization in Indonesia
2020 Standout
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
Skeletal infections: microbial pathogenesis, immunity and clinical management
2022 Standout
Lack of Exercise Is a Major Cause of Chronic Diseases
2012 Standout
Integrated genomic characterization of endometrial carcinoma
2013 StandoutNature
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer
2011
Analysis of anticancer drugs: A review
2011 Standout
Targeting the PI3K–AKT–mTOR pathway: progress, pitfalls, and promises
2008
Antisense, RNAi, and gene silencing strategies for therapy: Mission possible or impossible?
2008
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
2015 Standout
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
2011 Standout
Opioid-Induced Endocrinopathy in Cancer Patients: An Underestimated Clinical Problem
2014
Aging and cancer: The role of macrophages and neutrophils
2017
Polycystic ovary syndrome
2016 Standout
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
2009 Standout
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Cervical cancer
2019 Standout
Design of multifunctional non-viral gene vectors to overcome physiological barriers: Dilemmas and strategies
2011
Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
2008
RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
2010
American Association Of Clinical Endocrinologists, American College Of Endocrinology, And Androgen Excess And Pcos Society Disease State Clinical Review: Guide To The Best Practices In The Evaluation And Treatment Of Polycystic Ovary Syndrome - Part 2
2015
Targeting the mTOR Signaling Network for Cancer Therapy
2009
The Pharmacology of mTOR Inhibition
2009 Standout
Diabetes and Cancer
2010 Standout
Targeting the mTOR Pathway Using Deforolimus in Cancer Therapy
2009
Cancer statistics, 2016
2016 Standout
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Citrus flavonoids: Molecular structure, biological activity and nutritional properties: A review
2007 Standout
Myeloid-Derived Suppressor Cells Contribute to Staphylococcus aureus Orthopedic Biofilm Infection
2014
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
2014 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
A rapid and simple HPLC assay for quantification of capecitabine for drug monitoring purposes.
2010
mTOR: a pharmacologic target for autophagy regulation
2015 Standout
Sedentary Behavior and Cancer: A Systematic Review of the Literature and Proposed Biological Mechanisms
2010
Obesity and Cancer: The Role of Dysfunctional Adipose Tissue
2009
Antioxidant and Anti-Inflammatory Properties of the Citrus Flavonoids Hesperidin and Hesperetin: An Updated Review of their Molecular Mechanisms and Experimental Models
2014 Standout
Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505
2015
Works of Mark H. Einstein being referenced
Decentralizing Maternity Services to Increase Skilled Attendance at Birth and Antenatal Care Utilization in Rural Rwanda: A Prospective Cohort Study
2015
Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: A New York Cancer Consortium Study
2009
A phase II study of weekly topotecan and docetaxel in heavily treated patients with recurrent uterine and ovarian cancers
2009
Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice
2013
Pharmacokinetic and safety study of weekly irinotecan and oral capecitabine in patients with advanced solid cancers
2006
Metformin use and endometrial cancer survival
2013
Expression of COX-2, Ki-67, Cyclin D1, and P21 in Endometrial Endometrioid Carcinomas
2002
A phase I safety and dose escalation trial of docetaxel combined with GEM®231, a second generation antisense oligonucleotide targeting protein kinase A R1α in patients with advanced solid cancers
2005
A Prospective Evaluation of Insulin and Insulin-like Growth Factor-I as Risk Factors for Endometrial Cancer
2008
A phase II trial of the mTOR inhibitor AP23573 as a single agent in advanced endometrial cancer
2007